IceCure Medical
ICCM | NASDAQ
$0.76
+$0.03 (+4.11%)
At close: Nov 16, 2026, 4:00 PM ET
$0.80
+$0.04 (+5.26%)
After-hours:
Nov 16, 2026, 7:43 PM ET
IceCure Medical Company Profile
Company profile explainedCompany Profile
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Key Executives
| Name | Position |
|---|---|
| Eyal Shamir | Chief Executive Officer & Director |
| Meir Peleg | Chief Financial Officer |
| Shay Levav | Chief Operating Officer |
| Galit Malik | Vice President of Operations & Service |
| Merav Nir Dotan | Vice President of Human Resources |
| Shad Good | Vice President of Sales for North America |
| Tlalit Bussi Tel-Tzure | Vice President of Business Development & Global Marketing |
IceCure Medical
| Country | Israel |
| IPO Date | Aug 26, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 68 |
| CEO | Eyal Shamir |
Contact Details
7 Ha’Eshel Street Caesarea,
HA 3079504 Israel
Stock Details
| Ticker Symbol | ICCM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001584371 |
| CUSIP Number | M53071201 |
| ISIN Number | IL0011224156 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove ICCM